Observed versus predicted mortality after isolated tricuspid valve surgery. Issue 7 (6th April 2022)

• Record Type: Journal Article
• Authors: Russo, Marco; Saitto, Guglielmo; Lio, Antonio; Di Mauro, Michele; Berretta, Paolo; Taramasso, Maurizio; Scrofani, Roberto; Della Corte, Alessandro; Sponga, Sandro; Greco, Ernesto; Saccocci, Matteo; Calafiore, Antonio; Bianchi, Giacomo; Biondi, Andrea; Binaco, Irene; Della Ratta, Ester; Livi, Ugolino; Werner, Paul; De Vincentiis, Carlo; Ranocchi, Federico; Di Eusanio, Marco; Kocher, Alfred; Antona, Carlo; Miraldi, Fabio; Troise, Giovanni; Solinas, Marco; Maisano, Francesco; Laufer, Guenther; Musumeci, Francesco; Andreas, Martin
• Is Part Of: Journal of cardiac surgery. Volume 37:Issue 7(2022)
• Page Start: 1959
• Page End: 1966
• Publication Date: 2022-04-06
• Subjects: valve repair/replacement; Heart -- Surgery -- Periodicals; 617.412005
• DOI: 10.1111/jocs.16483
• Languages: English
• ISSNs: 0886-0440

Abstract

Abstract: Background: Aim of this study is to analyse the performances of Clinical Risk Score (CRS) and European System for Cardiac Operative Risk Evaluation (EuroSCORE)‐II in isolated tricuspid surgery. Methods: Three hundred and eighty‐three patients (54 ± 16 year; 54% female) were enrolled. Receiver operating characteristic analysis was performed to evaluate the relationship between the true positive fraction of test results and the false‐positive fraction for a procedure. Results: Considering the 30‐day mortality the area under the curve was 0.6 (95% confidence interval [CI] 0.50–0.72) for EuroSCORE II and 0.7 (95% CI 0.56–0.84) for CRS‐score. The ratio of expected/observed mortality showed underestimation when considering EuroSCORE‐II (min. 0.46–max. 0.6). At multivariate analysis, the CRS score ( p = .005) was predictor of late cardiac death. Conclusion: We suggest using both scores to obtain a range of expected mortality. CRS to speculate on late survival.